Children in the UK will be able to receive a new life-changing oral treatment for peanut allergies following approval for use by the National Institute for Health and Care Excellence (NICE).
NICE approved Palforzia after two large clinical trials into peanut allergy.
Much of this study was carried out in Manchester, including at the National Institute for Health Research (NIHR), Manchester Clinical Research Facility (CRF) at Royal Manchester Children’s Hospital (RMCH).